EX-23.1 2 f10k2019ex23-1_delmar.htm CONSENT OF ERNST & YOUNG, LLP

Exhibit 23.1

  

Consent of Independent Registered Public Accounting Firm

 

We consent to the incorporation by reference in the following Registration Statements:

 

(1)Registration Statement (Form S-3 No. 333-213600) of DelMar Pharmaceuticals, Inc. and in the related prospectus,

 

(2)Registration Statement (Form S-3 No. 333-213601) of DelMar Pharmaceuticals, Inc. and in the related prospectus, and

 

(3)Registration Statement (Form S-3 No. 333-229020) of DelMar Pharmaceuticals, Inc. and in the related prospectus;

 

of our report dated September 9, 2019, with respect to the consolidated financial statements of DelMar Pharmaceuticals, Inc. included in this Annual Report (Form 10-K) of DelMar Pharmaceuticals, Inc. for the year ended June 30, 2019.

 

Vancouver, Canada, /s/ Ernst & Young LLP
September 9, 2019 Chartered Professional Accountants